Featured Interview
Yinglu Guo: PSA screening test requires wider application in China
Translational Andrology and Urology
2012;
1
(4)
:199-201
.
(12 December 2012)
Editorial
Continuous or intermittent? On the dosing schedule of sunitinib for advanced renal cell carcinoma
Translational Andrology and Urology
2012;
1
(4)
:202-203
.
(12 December 2012)
Complete remission with tyrosine kinase inhibitors in renal cell carcinoma
Translational Andrology and Urology
2012;
1
(4)
:204-206
.
(12 December 2012)
Towards new treatment options for renal cell carcinoma: development and clinical results of tivozanib, a selective VEGFR tyrosine kinase inhibitor
Translational Andrology and Urology
2012;
1
(4)
:207-208
.
(12 December 2012)
Original Article
Assessment of risk factors of pediatric urolithiasis in Egypt
Translational Andrology and Urology
2012;
1
(4)
:209-215
.
(12 December 2012)
Review Article
Biomarkers for tyrosine kinase inhibitors in renal cell cancer
Translational Andrology and Urology
2012;
1
(4)
:216-222
.
(12 December 2012)
Mini-Review
Complications associated with percutaneous nephrolithotomy
Translational Andrology and Urology
2012;
1
(4)
:223-228
.
(12 December 2012)
Multi-peptide immunotherapeutic vaccine for renal cell carcinoma: getting the troops all worked up
Translational Andrology and Urology
2012;
1
(4)
:229-233
.
(12 December 2012)
Conversations in the operating room: history of the development of a promising new compound for the treatment of premature ejaculation
Translational Andrology and Urology
2012;
1
(4)
:234-238
.
(12 December 2012)
Expert Opinions on Challenging Cases
Commentary on the myths of Peyronie’s disease
Translational Andrology and Urology
2012;
1
(4)
:239-244
.
(12 December 2012)
Commentary
Micro-RNAs, next-generation molecular markers in male infertility field
Translational Andrology and Urology
2012;
1
(4)
:245-246
.
(12 December 2012)
